The objective of this review is to evaluate the beneficial and harmful effects of galsulfase 1 mg/kg IV infusion once weekly as long-term enzyme replacement therapy (ERT) in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) (MPS VI).
http://ift.tt/2kjpLL0
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Τετάρτη 25 Ιανουαρίου 2017
Galsulfase (Naglazyme) [Internet].
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου